Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 9, 2006, Pages 619-625

  Zhang, Bei ^a   Pan, J S ^a   Liu, J Y ^a   Han, S P ^a   Hu, G ^a   Wang, B ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chemotherapy; Cisplatin; Ovarian cancer; Radiation therapy; Survivin

Indexed keywords

CISPLATIN; COBALT 60; MESSENGER RNA; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADULT; AGED; APOPTOSIS; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RNA, MESSENGER;

EID: 33846390980     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.9.1003581     Document Type: Article

References (28)

1. Dinniwell, R., Lock, M., Pintilie, M. et al. Consolidative abdominopelvic radiotherapy after surgery and carboplatin paclitaxel chemotherapy for epithelial ovarian cancer. Int J Radiat Oncol Biol Phys 2005, 62: 104-10.
2. Yap, O.W., Kapp, D.S., Teng, N.N., Husain, A. Intraoperative radiation therapy in recurrent ovarian cancer. Int J Radiat Oncol Biol Phys 2005, 63: 1114-21.
3. LaCasse, E.C., Baird, S., Korneluk, R.G., MacKenzie, A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998, 17: 3247-59.
4. Jattela, M. Escaping cell death: Survival proteins in cancer. Exp Cell Res 1999, 248: 30-43.
5. Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., Altieri, D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 1998, 351: 882-3.
6. Ambrosini, G., Adida, C., Sirugo, G., Altieri, D.C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998, 273: 11177-82.
7. Nakamura, M., Tsuji, N., Asanuma, K. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity gastric cancer patients. Cancer Sci 2004, 1: 44-51.
8. Asanuma, K., Kobayashi, D., Furuya, D., Tsuji, N., Yagihashi, A., Watanabe, N. A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 2002, 93: 1057-62.
9. Buick, R.N., Pullano, R., Trent, T.M. et al. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985, 45: 3668-76.
10. Hamilton, T.C., Young, R.C., McKoy, W.M. et al. Characterization of human ovarian carcinoma cell line (NIH: OVCAR-3) androgen and estrogen receptors. Cancer Res 1983, 43: 5379-89.
11. Randall, K.G., Douglas, D.T., Tina, W. et al. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 1997, 65: 13-22.
12. Xu, G.X., Zhang, Y., Munir, S. et al. Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J Clin Endocrinol Metab 1989, 11: 5523-34.
13. Westphal, S., Kalthoff, H. Apoptosis: Targets in pancreatic cancer. Mol Cancer 2003, 7: 6-20.
14. Igney, F.H., Krammer, P.H. Death and anti-death: Tumour resistance to apoptosis. Nat Rev Cancer 2002, 2: 277-88.
15. Hager, J.H., Hanahan, D. Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis. Ann NY Acad Sci 1999, 887: 150-63.
16. Lu, C.D., Altieri, D.C., Tanigawa, N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998, 58: 1808-12.
17. Swana, H.S., Grossman, D., Anthony, J.N. et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999, 341: 452-3.
18. Ro, L., Yi, M., Carolyn, C. et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res 2004, 64: 2840-5.
19. Lo Muzio, L., Farina, A., Rubini, C. et al. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 2005, 225: 27-33.
20. Warnecke-Eberz, U., Hokita, S., Xi, H. et al. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Oncol Rep 2005, 13: 1241-6.
21. Tamm, I., Wang, Y., Sausville, E. et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Box, Caspases, and anticancer drugs. Cancer Res 1998, 58: 5315-20.
22. Kato, J., Kuwabara, Y., Mitani, M. et al. Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy. Int J Cancer 2001, 95: 92-5.
23. Johnson, A., Olsson, C., Anderson, H. et al. Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude mice. Cytometry 1994, 17: 142-50.
24. Crul, D., Schellens, J.H., Beijnen, J.H. et al. Cisplatin resistance and DNA repair. Cancer Treat Rev 1997, 23: 341-66.
25. Andrews, P.A., Howell, S.B. Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells 1990, 2: 35-43.
26. Wang, Z., Xie, Y., Wang, H. Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells. Cancer Biol Ther 2005, 4: 716-9.
27. Ikeguchi, M., Kaibara, N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med 2001, 8: 661-6.
28. Sui, M., Fan, W. Combination of radiation antagonizes the cytotoxic effects of vincristine and vinblastine in both mitotic arrest and apoptosis. Int J Radiat Oncol Biol 2005, 61: 1151-8.